Literature DB >> 12756242

Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression: evidence for peroxisome proliferator-activated receptor-alpha independent induction of UCP-2 expression.

Hans J Grav1, Karl J Tronstad, Oddrun A Gudbrandsen, Kjetil Berge, Kari E Fladmark, Tom C Martinsen, Helge Waldum, Hege Wergedahl, Rolf K Berge.   

Abstract

Lowering of plasma triglyceride levels by hypolipidemic agents is caused by a shift in the liver cellular metabolism, which become poised toward peroxisome proliferator-activated receptor (PPAR) alpha-regulated fatty acid catabolism in mitochondria. After dietary treatment of rats with the hypolipidemic, modified fatty acid, tetradecylthioacetic acid (TTA), the energy state parameters of the liver were altered at the tissue, cell, and mitochondrial levels. Thus, the hepatic phosphate potential, energy charge, and respiratory control coefficients were lowered, whereas rates of oxygen uptake, oxidation of pyridine nucleotide redox pairs, beta-oxidation, and ketogenesis were elevated. Moderate uncoupling of mitochondria from TTA-treated rats was confirmed, as the proton electrochemical potential (Delta(p)) was 15% lower than controls. The change affected the Delta(Psi) component only, leaving the (Delta)pH component unaltered, suggesting that TTA causes induction of electrogenic ion transport rather than electrophoretic fatty acid activity. TTA treatment induced expression of hepatic uncoupling protein 2 (UCP-2) in rats as well as in wild type and PPARalpha-deficient mice, accompanied by a decreased double bond index of the mitochondrial membrane lipids. However, changes of mitochondrial fatty acid composition did not seem to be related to the effects on mitochondrial energy conductance. As TTA activates PPARdelta, we discuss how this subtype might compensate for deficiency of PPARalpha. The overall changes recorded were moderate, making it likely that liver metabolism can maintain its function within the confines of its physiological regulatory framework where challenged by a hypolipemic agent such as TTA, as well as others.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756242     DOI: 10.1074/jbc.M303382200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

Review 2.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

3.  In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum.

Authors:  Oystein Bruserud; Karl Johan Tronstad; Rolf Berge
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-18       Impact factor: 4.553

4.  Effects of TCDD on the expression of nuclear encoded mitochondrial genes.

Authors:  Agnes L Forgacs; Lyle D Burgoon; Scott G Lynn; John J LaPres; Timothy Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-24       Impact factor: 4.219

5.  Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle.

Authors:  Bruno G Teodoro; Igor H Sampaio; Lucas H M Bomfim; André L Queiroz; Leonardo R Silveira; Anderson O Souza; Anna M A P Fernandes; Marcos N Eberlin; Tai-Yu Huang; Donghai Zheng; P Darrell Neufer; Ronald N Cortright; Luciane C Alberici
Journal:  J Physiol       Date:  2016-11-08       Impact factor: 5.182

6.  TCDD decreases ATP levels and increases reactive oxygen production through changes in mitochondrial F(0)F(1)-ATP synthase and ubiquinone.

Authors:  Howard G Shertzer; Mary Beth Genter; Dongxiao Shen; Daniel W Nebert; Ying Chen; Timothy P Dalton
Journal:  Toxicol Appl Pharmacol       Date:  2006-10-04       Impact factor: 4.219

7.  Uncoupling protein-2 up-regulation and enhanced cyanide toxicity are mediated by PPARalpha activation and oxidative stress.

Authors:  X Zhang; L Li; K Prabhakaran; L Zhang; H B Leavesley; J L Borowitz; G E Isom
Journal:  Toxicol Appl Pharmacol       Date:  2007-05-18       Impact factor: 4.219

8.  Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat.

Authors:  Elin Strand; Bodil Bjorndal; Ottar Nygard; Lena Burri; Christ Berge; Pavol Bohov; Bjørn J Christensen; Kjetil Berge; Hege Wergedahl; Asgaut Viste; Rolf K Berge
Journal:  Lipids Health Dis       Date:  2012-06-27       Impact factor: 3.876

9.  Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents.

Authors:  Bodil Bjørndal; Lena Burri; Vidar Staalesen; Jon Skorve; Rolf K Berge
Journal:  J Obes       Date:  2011-02-15

10.  PPARs in the Control of Uncoupling Proteins Gene Expression.

Authors:  Francesc Villarroya; Roser Iglesias; Marta Giralt
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.